Related Experiment Videos
Neural tissue engineering: from polymer to biohybrid organs
S Woerly1, G W Plant, A R Harvey
1Institut des Biomatériaux, Hôpital Saint-François d'Assise, Québec, Canada.
Biomaterials
|February 1, 1996
Summary
Researchers immobilized neuronal and glial cells within N-(2-hydroxypropyl) methacrylamide (HPMA) hydrogels. Viable cells maintained function, suggesting potential for central nervous system tissue replacement using these hybrid devices.
Area of Science:
- Biomaterials Science
- Neuroscience
- Cell Biology
Background:
- Neuronal and glial cell integration is crucial for central nervous system (CNS) repair.
- Developing biocompatible scaffolds that support cell viability and function is essential for neural tissue engineering.
Purpose of the Study:
- To immobilize neuronal and glial cells within N-(2-hydroxypropyl) methacrylamide (HPMA) polymer hydrogels.
- To assess cell viability, differentiation, and behavior within the hydrogel matrix.
- To explore the potential of these cell-based polymer constructs for CNS tissue replacement.
Main Methods:
- Cell immobilization via gel-entrapment within HPMA polymer networks.
- In vitro culture of cell-laden hydrogels for up to 6 days.
- Immunocytochemical analysis and image analysis for cell viability and differentiation.
- Scanning electron microscopy (SEM) for examining polymer structure and cell-polymer interactions.
Main Results:
- A proportion of immobilized neuronal and glial cells (Schwann cells, astrocytes) remained viable.
- Cells expressed their native antigenic profile, indicating sustained cellular integrity.
- Observed cell behaviors included spreading, process outgrowth, and secretion of laminin.
- SEM revealed structural interactions between the cells and the HPMA polymer network.
Conclusions:
- HPMA hydrogels can successfully immobilize and support the viability and function of neuronal and glial cells.
- The observed cell behaviors suggest the potential for these constructs in neural tissue regeneration.
- Cell-based polymer hybrid devices show promise for future applications in central nervous system tissue replacement.